Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Merck
Accenture
Queensland Health
Daiichi Sankyo
Chinese Patent Office
Teva
UBS
Citi

Generated: November 12, 2018

DrugPatentWatch Database Preview

Frovatriptan succinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for frovatriptan succinate and what is the scope of frovatriptan succinate freedom to operate?

Frovatriptan succinate is the generic ingredient in two branded drugs marketed by Endo Pharms, Glenmark Pharms Ltd, and Mylan Pharms Inc, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for frovatriptan succinate. Five suppliers are listed for this compound.

US Patents and Regulatory Information for frovatriptan succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 202931-001 Aug 28, 2014 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for frovatriptan succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ➤ Sign Up ➤ Sign Up
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ➤ Sign Up ➤ Sign Up
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ➤ Sign Up ➤ Sign Up
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ➤ Sign Up ➤ Sign Up
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Merck
Accenture
Queensland Health
Daiichi Sankyo
Chinese Patent Office
Teva
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.